Nature Reviews - Cardiology

MARCH 25, 2024

Nature Reviews Cardiology, Published online: 26 March 2024; doi:10.1038/s41569-024-00997-0 In this Review, Bozkurt provides an overview of the management of patients with heart failure across the full range of left ventricular ejection fraction, derived from the recommendations in the latest US and European guidelines.

Heart Failure 98

Heart Failure Pharmacology 98

HCPLive

APRIL 5, 2024

A clinical pharmacist reviews the various pharmacological aspects of the available adalimumab biosimilars.

Pharmacology 52

Pharmacology 52

Cardiovascular Diabetology

JUNE 30, 2024

The available evidence on the impact of specific non-pharmacological interventions on glycaemic control is currently limited. Consequently, there is a need to determine which interventions could provide the mo.

Pharmacology 144

Pharmacology Diabetes 144

HCPLive

AUGUST 14, 2024

A key opinion leaders explore effective non-pharmacological therapies and lifestyle modifications that have shown significant promise in managing fibromyalgia symptoms, complementing traditional medication-based approaches.

Pharmacology 52

Pharmacology 52

Circulation

FEBRUARY 5, 2024

This scientific statement discusses the mechanism of arrhythmias, pharmacological treatment options, and distinct aspects of pharmacokinetics for the fetus and neonate.

Pharmacology 78

Pharmacology Arrhythmia Physiology Circulation 78

Journal of the American Heart Association

FEBRUARY 25, 2025

In this scientific statement from the American Heart Association, we redefine maternal cardiovascular health to include psychological health, provide robust evidence on the association of psychological health with cardiovascular outcomes, highlight the social and environmental underpinnings, and finally, offer guidance about how to integrate psychological (..)

Pharmacology 75

Pharmacology Outcomes 75

American College of Cardiology

MAY 7, 2024

The following are key points to remember about a clinical guideline from the American College of Physicians (ACP) on newer pharmacologic treatments in adults with type 2 diabetes.

Pharmacology 49

Pharmacology Diabetes Article 49

Frontiers in Cardiovascular Medicine

JULY 7, 2024

Creation of disease models utilizing hiPSCs in combination with CRISPR/Cas9 gene editing enable mechanistic insights into differential pharmacological responses. RYR2 deficient cardiomyocytes show differential pharmacological responses to L-type channel calcium inhibitors.

Pharmacology 52

Pharmacology Heart Failure Outcomes 52

Journal of Cardiothoracic Surgery

JANUARY 9, 2025

Various pharmacological and non-pharmacological methods are available t. Removing the chest tube in cardiac patients after surgery is one of the worst experiences of hospitalization in the intensive care units.

Pharmacology 105

Pharmacology Hospital Research 105

Becker's Hospital Review - Cardiology

AUGUST 27, 2024

22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics. GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug.

Pharmacology 113

Pharmacology Obesity Diabetes 113

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

Furthermore, we utilized mass spectrometry analysis, network pharmacology, and lipidomics to predict the potential mechanisms of FFDS in the treatment of SCHD.ResultsFollowing treatment, FFDS demonstrated significant improvements in serum triglyceride levels (P=0.013) and a reduction in the frequency of angina episodes (P=0.021).

Heart Disease 52

Heart Disease Angina Cholesterol Pharmacology 52

Med Page Today

DECEMBER 12, 2023

Preventive Services Task Force (USPSTF) plans to recommend intensive behavioral interventions -- but not pharmacologic therapies -- for kids with a high body mass index (BMI). (MedPage Today) -- The U.S. In its draft recommendation statement.

Obesity 124

Obesity BMI Pharmacology 124

Circulation

DECEMBER 3, 2024

Critical components and policy initiatives include clinicians emphasizing the prevention of tobacco product initiation and supporting cessation with established pharmacological and behavioral tobacco dependence treatment therapies as primary goals for achieving an end to commercial tobacco and nicotine addiction.

Cardiovascular Disease 73

Cardiovascular Disease Cerebrovascular Disease Pharmacology Biomarkers 73

Heart BMJ

DECEMBER 13, 2024

3 Should we continue with a conservative, stepwise approach, beginning with pharmacological management and delaying intervention until MR severity worsens? 2 As the clinical understanding of SMR evolves, so too does the debate over the optimal treatment strategy.

Pharmacology 52

Pharmacology Bicuspid/Mitral Heart Failure Outcomes 52

Journal of Cardiovascular Electrophysiology

MARCH 10, 2025

This constellation of disease states has its own unique epidemiologic features, pathophysiology, experimental and clinical mechanisms; and an increasing knowledge base with respect to clinical presentation, prognostic implications, and therapeutic options from pharmacologic advances and non-pharmacologic interventions.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Pharmacology 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Long-term management approaches for INOCA patients, including pharmacologic therapies and lifestyle interventions, are reviewed. The paper discusses a potential interference between vasodilators used in trans-radial access and coronary spasm testing.

Ischemia 52

Ischemia Angina Pharmacology Stenosis 52

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

The control group received conventional antiarrhythmic therapy with -blockers or propafenone, and the EECP group underwent EECP therapy in conjunction with pharmacological treatment. Patients were randomly assigned to either the control group (n=50) or the EECP group (n=50) in this randomized controlled trial.

Atrial Fibrillation 52

Atrial Fibrillation Blood Pressure Pharmacology Ultrasound 52

JAMA Cardiology

OCTOBER 26, 2024

This substudy of the Danish-German (DanGer) Shock randomized clinical trial investigates if the use of a microaxial flow pump reduces the need for pharmacological support and what the effects are on hemodynamics and lactate clearance in patients with ST-elevation myocardial infarction–induced cardiogenic shock.

Cardiogenic Shock 110

Cardiogenic Shock Myocardial Infarction Pharmacology 110

The British Journal of Cardiology

MAY 24, 2024

Optimal pharmacological and non-pharmacological management (including device treatment) have had an enormous beneficial impact on the clinical course of HF. This module will focus on lifestyle modifications and pharmacological treatment.

Pharmacology 40

Pharmacology Heart Failure 40

American Heart News - Heart News

FEBRUARY 25, 2025

Statement Highlights: It is essential for health care professionals to routinely screen pregnant and postpartum women for depression and anxiety, address modifiable risk factors and consider behavioral and pharmacological interventions to improve.

Pharmacology 102

Pharmacology Risk Factors 102

Open Heart

MARCH 28, 2025

Methods Relevant studies examining arrhythmia in both exercise and pharmacological stress testing were searched for in PubMed, Embase and Cochrane databases from inception to 14 June 2023. Objectives To determine the significance of stress test-induced arrhythmias.

Arrhythmia 52

Arrhythmia Coronary Artery Disease Myocardial Infarction Atrial Fibrillation 52

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

In this narrative review, we discuss the pathophysiology of CS, novel phenotypes, evolving definitions and staging systems, currently available pharmacologic and device-based therapies, standardized, team-based management protocols, and regionalized systems-of-care aimed at improving shock outcomes.

Cardiogenic Shock 145

Cardiogenic Shock Pharmacology Outcomes Research 145

Journal of Clinical Investigation - Cardiology

OCTOBER 15, 2024

Although no pharmacological interventions are yet approved for CUD, we present the most promising pharmacological interventions being tested.

Pharmacology 94

Pharmacology Innovation Risk Factors 94

HeartRhythm

FEBRUARY 8, 2025

Pharmacological treatments, including quinidine, cilostazol, and bepridil, offer alternative approaches for VF prevention, particularly for patients experiencing recurrent VF after implantable cardioverter defibrillator (ICD) implantation.1

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology Defibrillator 40

HCPLive

SEPTEMBER 26, 2024

The FDA approves Cobenfy, the first pharmacological approach to treating schizophrenia since the 1970s.

Pharmacology 83

Pharmacology 83

Open Heart

MARCH 25, 2025

Background Current pharmacological approaches for the treatment of orthostatic hypotension (OH) may detrimentally affect supine blood pressure (BP). This side effect is often unacceptable and limits the utility of medical management.

Blood Pressure 52

Blood Pressure Pharmacology Hypertension 52

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Therefore, optimal secondary prevention includes managing BP through lifestyle changes and pharmacological therapy. Several modifiable risk factors, including increased blood pressure (BP), significantly contribute to cardiovascular risk in CCS.

Blood Pressure 52

Blood Pressure Pharmacology Document Risk Factors 52

Journal of Cardiovascular Pharmacology

JUNE 3, 2024

A variety of technologies, including network pharmacology, RNA-sequencing, immunohistochemistry, and Western blotting were performed to investigate its underlying mechanisms.

Pharmacology 40

Pharmacology Hypertension Technology Article 40

Journal of Clinical Investigation - Cardiology

SEPTEMBER 3, 2024

Together, these findings offer critical insights into the functional role of LSGLP-1R neurons in the physiological regulation of energy homeostasis and delineate their instrumental role in mediating the pharmacological efficacy of liraglutide.

Pharmacology 117

Pharmacology Physiology Obesity 117

HCPLive

JUNE 26, 2024

Jennifer Goldman, RPh, PharmD, discusses how the pharmacologic advancements in recent years have shifted discussion around lipid, and cardiovascular risk, management in diabetes.

Diabetes 81

Diabetes Pharmacology 81

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

The increasing prevalence of heart failure (HF) has led to advancements in therapeutic strategies, including the development of new pharmacological treatments and the expansion of guideline recommendations across the spectrum of left ventricular ejection fractions.

Heart Failure 52

Heart Failure Heart Transplant Pharmacology Transplant 52

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Results Pharmacological/non-pharmacological secondary prevention methods have been efficiently applied. Baseline aggregometry indicated platelet hyperactivity, decreasing gradually and being significantly reduced late, at 12 months ( p  < 0.05).

Laboratory 111

Laboratory Pharmacology Biomarkers 111

Journal of Clinical Investigation - Cardiology

FEBRUARY 1, 2024

Pharmacologic CTH inhibition suppressed glioblastoma invasion, while CTH knockdown slowed glioblastoma invasion in vivo. A CRISPR metabolic gene screen revealed cystathionine γ-lyase (CTH), which converts cystathionine to the nonessential amino acid cysteine in the transsulfuration pathway, to be essential for glioblastoma invasion.

Pharmacology 136

Pharmacology 136

Stroke Journal

JANUARY 30, 2025

Here we tested our hypothesis that pharmacological inhibition of TGFR2 in mice models of dementia may reduce RTN gliosis, breathing disorder and cognitive impairment.We TGFR2 pharmacological inhibition additionally reduced astrogliosis in the RTN of Tg-2576 mice (drug 53.624.8 vs. 58.25.16, p=.03 03 n=7/group) and NORT (59.13.28

Pharmacology 40

Pharmacology Dementia Strokes Stroke 40

European Journal of Heart Failure

JANUARY 17, 2025

Temporal change in such biomarkers, particularly in response to pharmacological interventions and/or mechanical circulatory support, can guide management and predict outcome. Biomarkers that aid prediction and early detection of CS, provide early signs of organ dysfunction and define prognosis could help optimize management.

Cardiogenic Shock 75

Cardiogenic Shock Biomarkers Pharmacology Circulation 75

Hypertension Journal

JANUARY 2, 2024

Pharmacological inhibition of EGFR or downstream ER stress may be a promising therapeutic strategy for preventing aneurysm rupture and subarachnoid hemorrhage.

Aneurysm 45

Aneurysm Pharmacology Atherosclerosis Hemorrhage 45

Circulation

FEBRUARY 9, 2025

Circulation, Volume 151, Issue 6 , Page 400-415, February 11, 2025. Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures.

Pharmacology 49

Pharmacology Cardiovascular Disease Plaque Risk Factors 49